Can we predict flu-like symptoms in patients with multiple sclerosis treated with interferon-β?

被引:7
|
作者
Montalban, X [1 ]
Durán, I [1 ]
Río, J [1 ]
Sáez-Torres, I [1 ]
Tintoré, M [1 ]
Martínez-Cáceres, EM [1 ]
机构
[1] Hosp Gen Univ Valle Hebron, Serv Neurol, Unitat Neuroimmunol Clin, Barcelona, Spain
关键词
multiple sclerosis; flu-like symptoms; interferon-beta(1b); interleukin-6;
D O I
10.1007/s004150050580
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Interferon-beta(1b) treatment in relapsing-remitting multiple sclerosis can frequently induce systemic side effects such as flu-like symptoms with fever. In vitro stimulation of peripheral blood leukocytes with interferon-beta(1b) before the beginning of therapy shows that patients who develop fever generally have increased levels of interleukin-6.
引用
收藏
页码:259 / 262
页数:4
相关论文
共 50 条
  • [21] A phase 4 study of acetaminophen and prednisone in the management of flu-like symptoms in patients with relapsing multiple sclerosis receiving intramuscular interferon β-1a
    Freedman, M.
    Buffels, R.
    You, X.
    Foulds, P.
    JOURNAL OF NEUROLOGY, 2009, 256 : S125 - S125
  • [26] A PERSISTENT FLU-LIKE SYNDROME IN PATIENTS TREATED WITH ERYTHROPOIETIN
    GRETZ, N
    LASSERRE, JJ
    DRESCHER, P
    GREGERSCHULZE, S
    STEGMEIER, K
    STRAUCH, M
    NEFROLOGIA, 1990, 10 : 148 - 152
  • [27] Is it the flu or anthrax? A decision analytic approach to the management of patients with flu-like symptoms
    Fine, AM
    Fraser, HSF
    Fleisher, GR
    Mandl, KD
    PEDIATRIC RESEARCH, 2002, 51 (04) : 132A - 132A
  • [28] TRPV1 polymorphisms and risk of interferon β-induced flu-like syndrome in patients with relapsing-remitting multiple sclerosis
    Buttari, Fabio
    Zagaglia, Sara
    Marciano, Lorenzo
    Albanese, Maria
    Landi, Doriana
    Nicoletti, Carolina Gabri
    Mercuri, Nicola Biagio
    Silvestrini, Mauro
    Provinciali, Leandro
    Marfia, Girolama Alessandra
    Mori, Francesco
    Centonze, Diego
    JOURNAL OF NEUROIMMUNOLOGY, 2017, 305 : 172 - 174
  • [29] Binding antibodies to interferon-β in Iranian multiple sclerosis patients treated with different interferon-β preparations
    Vaezeafshar, R
    Hooshmand, E
    Jangouk, P
    Amirzargar, A
    Nikbin, B
    Lotfi, J
    Soltanzodeh, S
    MULTIPLE SCLEROSIS, 2004, 10 (7032): : S253 - S253
  • [30] Pharmacogenetics of MXA SNPs in interferon-β treated multiple sclerosis patients
    Weinstock-Guttman, Bianca
    Tamano-Blanco, Miriam
    Bhasi, Kavitha
    Zivadinov, Robert
    Ramanathan, Murali
    JOURNAL OF NEUROIMMUNOLOGY, 2007, 182 (1-2) : 236 - 239